Zogenix, Inc. announced that James B. Breitmeyer, M.D., Ph.D., has been appointed as a new member of the company's Board of Directors. Dr. Breitmeyer currently serves as President of Bavarian Nordic, Inc. He is also Executive Vice President of Bavarian A/S. He previously served as the acting Chief Medical Officer of Zogenix, Inc. in an advisory capacity, the Executive Vice President of Development and Chief Medical Officer of Cadence Pharmaceuticals, Inc., and the Chief Medical Officer of Applied Molecular Evolution Inc.